Stay updated with breaking news from Liver Microphysiological System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This article explores how a liver-on-a-chip model of fatty liver disease could help in preventing a globalhealthcare crisis.
The FDA Expands Collaboration With CN Bio to Investigate Lung-on-a-chip Model for Inhaled Drug Evaluation Applications Follows success of initial project demonstrating the advanced performance of the Company's liver-on-a-chip platform CN Bio, a leading developer of single- and multi-organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, today announced the U.S. Food and Drug Administration (FDA) has extended their research collaboration, for a further three years. The scope of the research carried out with the FDA's Center for Drug Evaluati...
CN Bio's PhysioMimix Technology Receives FDA Recognition Represents the first co-published, peer-reviewed article between a microphysiological system provider and a regulator CN Bio, a leading developer of single and multi organ-on-chip microphysiological systems (MPS) that improve the accuracy and efficiency of drug discovery, today announced the publication of co-authored research with the U.S. Food and Drug Administration (FDA) 1. The first co-published, peer-reviewed research paper between a commercial MPS provider and a regulator, demonstrates that data derived using CN Bio's proprietary...